DETERMINING THE OPTIMAL DOSAGE FOR M-TABLET TO MAXIMIZE CONVENIENCE AND PATIENT COMPLIANCE

Authors

  • Rajiv Dhawan Maharishi Markandeshwar University, Mullana, Ambala, Harayana, India
  • Jaspreet Kaur Batth Khalsa College of Pharmacy, Amritsar, Punjab, India

DOI:

https://doi.org/10.37547/ajbspi/Volume03Issue05-06

Keywords:

m-Tablet, medication compliance, dosage optimization

Abstract

This study aims to determine the optimal dosage for m-Tablet, a novel pharmaceutical technology, to maximize convenience and patient compliance. Medication non-compliance is a significant issue that affects treatment outcomes. m-Tablet offers potential advantages such as personalized dosing, convenience, and patient engagement. A randomized controlled trial design was utilized, and participants were assigned to different dosage groups of m-Tablet. Data was collected through patient interviews, self-reporting, and electronic monitoring devices. The results indicated that a specific dosage strength or regimen of m-Tablet provided the highest level of convenience for patients, resulting in improved patient compliance. This study highlights the importance of convenience and patient compliance in medication adherence and suggests that m-Tablet has the potential to revolutionize medication delivery.

References

• Jain N K, Sharma S N. A Text book of professional pharmacy. Vallabh Prakashan , 2016.

• Lachman L, Lieberman H A, Joseph L. Kanig. The theory and Practice of Industrial Pharmacy. Varghese publication house, 1990.

• Bhalla H L, Handa, A K. Development and Evaluation of Controlled Release Tablets of CBZ. Indian Drugs1999; 36(2): 100 -105.

• Chein YW. Novel drug delivery systems, In: chein YW, ed. Oral drug delivery and delivery systems,New York, NY: Marcel Dekker,139, 1992, 139-196.

• Vyas S P, Khar. Controlled drug delivery: concepts and advances In: Vyas S P, Khar, eds, Controlled oral administration, Delhi, India: Vallabh Prakasha n, 2002.

• Allen L. V, Ansel H. C. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. Philadelphia: Lippincott Williams and Wilkins. 2014.

• Dash A. Solid Dosage Forms. In A. Dash, S. Singh and J. Tolman (Eds), Pharmaceutics: Basic Principles and Application to Pharmacy. USA: Elsevier Inc. 2014

• Debjit B, Duraivel S, Rajalakshmi A, Sampath K. Tablet manufacturing process and defects of

• tablets . Elixir Pharmacy 2014; 70(2): 24368-24374.

• Jones D. Fasttrack Pharmaceutics – Dosage Form and Design. London: Pharmaceutical Press. 2008.

• Kottke M, Rudnic E. Tablet Dosage Forms. In G. Banker and C. Rhodes , Modern Pharmaceutics. New York: Marcel Dekker, Inc. 2002

• Ofoefule S I. Textbook of Pharmaceutical Technology and Industrial Pharmacy . Nigeria: Samakin (Nig) Enterprise. 2002

• Sakr A A, Alanazi F K . Oral Solid Dosage Form. In L.A Felton. Remington Essentials of Pharmaceutics. London: Pharmaceutical Press. 2012

• Shayne C. G. Pharmaceutical Manufacturing Handbook Production and Processes. New Jersey: John Wiley & Sons, Inc. 2008

• Ashoka V Bhosle; Rahul V Tukawalw and sanjay D Sawant; Oral Novel DrugDelivery System; The Eastern Pharmacist; 2002;41-43.

• Vergeire-Dalmacion G. Usefulness of Cost Effectiveness: Evidence versus Applicability. Pharm Anal Acta, 2016; 7: 456.

Downloads

Published

2023-05-23

How to Cite

Rajiv Dhawan, & Jaspreet Kaur Batth. (2023). DETERMINING THE OPTIMAL DOSAGE FOR M-TABLET TO MAXIMIZE CONVENIENCE AND PATIENT COMPLIANCE. American Journal Of Biomedical Science & Pharmaceutical Innovation, 3(05), 44–47. https://doi.org/10.37547/ajbspi/Volume03Issue05-06